Original language | English |
---|---|
Pages (from-to) | 299-300 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 398 |
Issue number | 10297 |
DOIs | |
State | Published - 24 Jul 2021 |
Externally published | Yes |
Tocilizumab in COVID-19 therapy: who benefits, and how?
Avidan U. Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov
Research output: Contribution to journal › Letter › peer-review
5
Scopus
citations